Bridging Lab to Patient with Brian Wamhoff | Charlottesville News

Brian Wamhoff, a rare biotech leader with hands-on experience from lab to patient, has been tapped as the first chief strategy and business officer for the new Manning Institute of Biotechnology at UVA — a bold move to bridge the gap between scientific discovery and real medicine. With a mission to accelerate treatments and close the “translational valley of death,” Wamhoff will connect the institute with investors, partners, and agencies to turn breakthroughs into bedside solutions faster — even as a $27 million state funding cut forces the team to find new financial pathways. The institute, set to open in late 2027, is racing to deliver life-saving drugs to patients who are waiting. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/417df0033d6a3448